Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05287906 · ClinicalTrials.gov registry record · NA
A Trial to Assess Steviol Glycosides on Acute Appetite Hormone Release
A NA study of Type 2 Diabetes Mellitus and Overweight and Obesity, sponsored by Midwest Center for Metabolic and Cardiovascular Research.
- Completed
- Registry status
- NA
- Development phase
- 69
- Enrollment target
- 3
- Study locations
NCT05287906: Completed NA study of Type 2 Diabetes Mellitus and Overweight and Obesity, sponsored by Midwest Center for Metabolic and Cardiovascular Research.
NCT05287906 is a NA study of Type 2 Diabetes Mellitus and Overweight and Obesity that has completed, run by Midwest Center for Metabolic and Cardiovascular Research. The registered enrollment target is 69 participants, below the 2,959-participant average among 130 other Type 2 Diabetes Mellitus trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05287906, a NA study of Type 2 Diabetes Mellitus and Overweight and Obesity, has completed, sponsored by Midwest Center for Metabolic and Cardiovascular Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
- 3
- Study locations
Study Summary
The objectives of this trial are to assess the effects of steviol glycoside alone or in combination with a glycemic carbohydrate on blood glucose and endocrine and gut hormone secretion vs. water and glucose in individuals with normal weight, overweight and type 2 diabetes mellitus (T2DM).
Primary Outcome
Changes or percent changes from baseline to the end of treatment
Conditions Studied
Interventions
- OTHER Water
- OTHER Glucose
- OTHER Steviol Glycosides
- OTHER Steviol Glycosides plus glucose
- OTHER Rebaudioside A
Study Locations (3)
Florida
- Excellence Medical and Research - Miami Gardens
- Advanced Research for Health Improvement - Naples
Illinois
- Great Lakes Clinical Trials - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2022-04-15 |
| Est. Completion | 2024-06-05 |
| Phase | NA |
What the finished NCT05287906 record still lists
NCT05287906 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 69 participants, a relatively small participant target, below the 2,959-participant average among 130 other Type 2 Diabetes Mellitus trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 5 interventions - of which Water is the first listed.
NCT05287906 reports a single indexed study location in Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT05287906 about?
NCT05287906 is a clinical study titled "A Trial to Assess Steviol Glycosides on Acute Appetite Hormone Release". The objectives of this trial are to assess the effects of steviol glycoside alone or in combination with a glycemic carbohydrate on blood glucose and endocrine and gut hormone secretion vs. water and glucose in individuals with normal weight, overweight and type 2 diabetes mellitus (T2DM).
What is the current status of trial NCT05287906?
This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2022-04-15. Estimated completion is 2024-06-05.
What conditions does trial NCT05287906 study?
This clinical trial studies the following conditions: Type 2 Diabetes Mellitus, Overweight and Obesity.
What interventions are being tested in trial NCT05287906?
The interventions under investigation include: Water (OTHER), Glucose (OTHER), Steviol Glycosides (OTHER), Steviol Glycosides plus glucose (OTHER), Rebaudioside A (OTHER).
Who is sponsoring clinical trial NCT05287906?
This trial is sponsored by Midwest Center for Metabolic and Cardiovascular Research, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05287906 being conducted?
This trial has 3 study locations across Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05287906's enrollment target sits among peer trials
69 68th of 130 higher than 62 of 130 other Type 2 Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preventing Type 2 Diabetes in Black Emergent Adult
RECRUITING · NA
-
The GRoceries Aimed at Increasing Nutrition Study
RECRUITING · NA
-
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
RECRUITING · NA
-
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes
RECRUITING · NA
-
Impact of Metabolic Health on Sperm Epigenetic Marks in Humans
ACTIVE NOT RECRUITING · NA
-
Is the Degree of Perceived Effort During Resistance Exercise Important for Improvements in Blood Glucose
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04020575 · 69 participants · Phase 1
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
- NCT04163614 · 69 participants · NA
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
- NCT04164641 · 69 participants · NA
Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration
- NCT04493372 · 69 participants · NA
Deciphering Preserved Autonomic Function After Spinal Cord Injury
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI